395 related articles for article (PubMed ID: 17060542)
1. Prognostic factors and antibiotics in Vibrio vulnificus septicemia.
Liu JW; Lee IK; Tang HJ; Ko WC; Lee HC; Liu YC; Hsueh PR; Chuang YC
Arch Intern Med; 2006 Oct; 166(19):2117-23. PubMed ID: 17060542
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study.
Chen SC; Chan KS; Chao WN; Wang PH; Lin DB; Ueng KC; Kuo SH; Chen CC; Lee MC
Crit Care Med; 2010 Oct; 38(10):1984-90. PubMed ID: 20657269
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for primary septicemia and wound infection caused by Vibrio vulnificus.
Chou TN; Lee YT; Lai YY; Chao WN; Yang C; Chen CC; Wang PH; Lin DB; Wong RH; Chen SC
Am J Emerg Med; 2010 May; 28(4):424-31. PubMed ID: 20466220
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period.
Chen SC; Lee YT; Tsai SJ; Chan KS; Chao WN; Wang PH; Lin DB; Chen CC; Lee MC
J Antimicrob Chemother; 2012 Feb; 67(2):488-93. PubMed ID: 22117030
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
Kim SE; Shin SU; Oh TH; Kim UJ; Darboe KS; Kang SJ; Jang HC; Jung SI; Shin HY; Park KH
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007478. PubMed ID: 31188821
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
[TBL] [Abstract][Full Text] [Related]
9. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis.
Chao WN; Tsai CF; Chang HR; Chan KS; Su CH; Lee YT; Ueng KC; Chen CC; Chen SC; Lee MC
Am J Surg; 2013 Jul; 206(1):32-9. PubMed ID: 23414632
[TBL] [Abstract][Full Text] [Related]
10. Atypical manifestation of Vibrio vulnificus septicaemia.
Lin LW; Hung SW; Lin CS; Liu CL; Chong CF
Emerg Med J; 2006 Jun; 23(6):e39. PubMed ID: 16714493
[TBL] [Abstract][Full Text] [Related]
11. Vibrio vulnificus infection: diagnosis and treatment.
Bross MH; Soch K; Morales R; Mitchell RB
Am Fam Physician; 2007 Aug; 76(4):539-44. PubMed ID: 17853628
[TBL] [Abstract][Full Text] [Related]
12. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis.
Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734
[TBL] [Abstract][Full Text] [Related]
13. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
14. [Necrotizing dermatitis due to Vibrio Vulnificus].
Dieng MT; Niang SO; Ly F; Bathily T; Ndiaye B
Ann Dermatol Venereol; 2001 May; 128(5):653-5. PubMed ID: 11427803
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection.
Horseman MA; Surani S
Int J Infect Dis; 2011 Mar; 15(3):e157-66. PubMed ID: 21177133
[TBL] [Abstract][Full Text] [Related]
16. Seasonality, clinical types and prognostic factors of Vibrio vulnificus infection.
Tsao CH; Chen CC; Tsai SJ; Li CR; Chao WN; Chan KS; Lin DB; Sheu KL; Chen SC; Lee MC; Bell WR
J Infect Dev Ctries; 2013 Jul; 7(7):533-40. PubMed ID: 23857388
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
[TBL] [Abstract][Full Text] [Related]
18. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
19. Tubo-ovarian abscess caused by Vibrio vulnificus.
Midturi J; Baker D; Winn R; Fader R
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):131-3. PubMed ID: 15698719
[TBL] [Abstract][Full Text] [Related]
20. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
